L
Lineage Cell Therapeutics Inc
F:BT3
Lineage Cell Therapeutics Inc
F:BT3
Price:
1.064
EUR
-5%
Market Closed
Market Cap:
€200.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
Secom Co Ltd
TSE:9735
|
JP |
|
Osisko Metals Inc
TSX:OM
|
CA |
|
V
|
Veolia Environnement SA
XMUN:VVD
|
FR |
|
V
|
Vinci SA
OTC:VCISY
|
FR |
|
Coveo Solutions Inc
TSX:CVO
|
CA |
|
E
|
Electro Optic Systems Holdings Ltd
OTC:EOPSF
|
AU |
|
Delek US Holdings Inc
NYSE:DK
|
US |
|
AGNC Investment Corp
NASDAQ:AGNC
|
US |
|
Exelixis Inc
NASDAQ:EXEL
|
US |
|
G-III Apparel Group Ltd
NASDAQ:GIII
|
US |
|
Telekom Austria AG
F:TA1
|
AT |
|
U
|
UniCredit SpA
OTC:UNCFF
|
IT |
|
V
|
Veidekke ASA
OSE:VEI
|
NO |
|
E
|
ESE Entertainment Inc
OTC:ENTEF
|
CA |
|
Dicker Data Ltd
ASX:DDR
|
AU |
|
Tapestry Inc
NYSE:TPR
|
US |
|
B
|
Bank of China Ltd
OTC:BACHF
|
CN |
|
A
|
Atlas Copco AB
F:ACO2
|
SE |
|
Palo Alto Networks Inc
BMV:PANW
|
US |
|
Dal'nevostochnoye Morskoye Parokhodstvo PAO
MOEX:FESH
|
RU |
Wall St Price Targets
BT3 Price Targets Summary
Lineage Cell Therapeutics Inc
Lineage Cell Therapeutics Inc
Wall Street analysts forecast BT3 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for BT3 is 5.779 EUR with a low forecast of 3.121 EUR and a high forecast of 9.734 EUR.
Lowest Forecast
Price Target
3.121
EUR
193% Upside
Average Forecast
Price Target
5.779
EUR
443% Upside
Highest Forecast
Price Target
9.734
EUR
815% Upside
Lineage Cell Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BT3's stock price target?
Price Target
5.779
EUR
5.779
EUR
According to Wall Street analysts, the average 1-year price target for BT3 is 5.779 EUR with a low forecast of 3.121 EUR and a high forecast of 9.734 EUR.
What is the Revenue forecast for Lineage Cell Therapeutics Inc?
Projected CAGR
58%
58%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 58%.
